A bidirectional switch in the Shank3 phosphorylation state biases synapses toward up- or downscaling

Homeostatic synaptic plasticity requires widespread remodeling of synaptic signaling and scaffolding networks, but the role of posttranslational modifications in this process has not been systematically studied. Using deepscale, quantitative analysis of the phosphoproteome in mouse neocortical neurons, we found wide-spread and temporally complex changes during synaptic scaling up and down. We observed 424 bidirectionally modulated phosphosites that were strongly enriched for synapse-associated proteins, including S1539 in the ASD-associated synaptic scaffold protein Shank3. Using a parallel proteomic analysis performed on Shank3 isolated from rat neocortical neurons by immunoaffinity, we identified two sites that were hypo-phosphorylated during scaling up and hyper-phosphorylated during scaling down: one (rat S1615) that corresponded to S1539 in mouse, and a second highly conserved site, rat S1586. The phosphorylation status of these sites modified the synaptic localization of Shank3 during scaling protocols, and dephosphorylation of these sites via PP2A activity was essential for the maintenance of synaptic scaling up. Finally, phosphomimetic mutations at these sites prevented scaling up but not down, while phosphodeficient mutations prevented scaling down but not up. Thus, an activity-dependent switch between hypo- and hyperphosphorylation at S1586/ S1615 of Shank3 enables scaling up or down, respectively. Collectively our data show that activity-dependent phosphoproteome dynamics are important for the functional reconfiguration of synaptic scaffolds, and can bias synapses toward upward or downward homeostatic plasticity.

[1]  E. Schuman,et al.  Dynamic bi-directional phosphorylation events associated with the reciprocal regulation of synapses during homeostatic up- and down-scaling , 2021, bioRxiv.

[2]  K. Roche,et al.  CaMKII Phosphorylation Regulates Synaptic Enrichment of Shank3 , 2021, eNeuro.

[3]  Jen Q. Pan,et al.  Neurogranin, Encoded by the Schizophrenia Risk Gene NRGN, Bidirectionally Modulates Synaptic Plasticity via Calmodulin-Dependent Regulation of the Neuronal Phosphoproteome , 2020, Biological Psychiatry.

[4]  E. Kavalali,et al.  Targeting Homeostatic Synaptic Plasticity for Treatment of Mood Disorders , 2020, Neuron.

[5]  E. Schuman,et al.  Proteome dynamics during homeostatic scaling in cultured neurons , 2020, eLife.

[6]  Keith B. Hengen,et al.  Autism-Associated Shank3 Is Essential for Homeostatic Compensation in Rodent V1 , 2020, Neuron.

[7]  D. Nair,et al.  Differential Scaling of Synaptic Molecules within Functional Zones of an Excitatory Synapse during Homeostatic Plasticity , 2020, eNeuro.

[8]  R. Huganir,et al.  Tyrosine phosphorylation of the AMPA receptor subunit GluA2 gates homeostatic synaptic plasticity , 2020, Proceedings of the National Academy of Sciences.

[9]  R. Colbran,et al.  CaMKIIα phosphorylation of Shank3 modulates ABI1-Shank3 interaction. , 2020, Biochemical and biophysical research communications.

[10]  G. Turrigiano,et al.  Sleep Promotes Downward Firing Rate Homeostasis , 2019, Neuron.

[11]  J. Vilo,et al.  g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update) , 2019, Nucleic Acids Res..

[12]  S. Carr,et al.  TMT Labeling for the Masses: A Robust and Cost-efficient, In-solution Labeling Approach* , 2019, Molecular & Cellular Proteomics.

[13]  Matthew T. Dickerson,et al.  Neuronal L-Type Calcium Channel Signaling to the Nucleus Requires a Novel CaMKIIα-Shank3 Interaction , 2019, bioRxiv.

[14]  H. Zoghbi,et al.  A kinome-wide RNAi screen identifies ERK2 as a druggable regulator of Shank3 stability , 2019, Molecular Psychiatry.

[15]  H. Zoghbi,et al.  An autism-linked missense mutation in SHANK3 reveals the modularity of Shank3 function , 2019, Molecular Psychiatry.

[16]  R. Huganir,et al.  The AMPA Receptor Code of Synaptic Plasticity , 2018, Neuron.

[17]  A. Carvalho,et al.  Stargazin Dephosphorylation Mediates Homeostatic Synaptic Downscaling of Excitatory Synapses , 2018, Front. Mol. Neurosci..

[18]  Ronald J. Moore,et al.  Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry , 2018, Nature Protocols.

[19]  Anna C. Salzberg,et al.  Activity-Induced Regulation of Synaptic Strength through the Chromatin Reader L3mbtl1. , 2018, Cell reports.

[20]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[21]  E. Schuman,et al.  Time- and polarity-dependent proteomic changes associated with homeostatic scaling at central synapses , 2018, eLife.

[22]  R. Huganir,et al.  Neuropilin-2/PlexinA3 Receptors Associate with GluA1 and Mediate Sema3F-Dependent Homeostatic Scaling in Cortical Neurons , 2017, Neuron.

[23]  Tae-Kyung Kim,et al.  An Intrinsic Transcriptional Program Underlying Synaptic Scaling during Activity Suppression. , 2017, Cell reports.

[24]  E. Schuman,et al.  Nascent Proteome Remodeling following Homeostatic Scaling at Hippocampal Synapses , 2016, Neuron.

[25]  T. O'Dell,et al.  Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome , 2016, Science Signaling.

[26]  S. Nelson,et al.  Upregulation of μ3A Drives Homeostatic Plasticity by Rerouting AMPAR into the Recycling Endosomal Pathway. , 2016, Cell reports.

[27]  A. Carvalho,et al.  Mechanisms of homeostatic plasticity in the excitatory synapse , 2016, Journal of neurochemistry.

[28]  K. Woolfrey,et al.  Coordination of Protein Phosphorylation and Dephosphorylation in Synaptic Plasticity* , 2015, The Journal of Biological Chemistry.

[29]  R. Huganir,et al.  GRIP1 is required for homeostatic regulation of AMPAR trafficking , 2015, Proceedings of the National Academy of Sciences.

[30]  G. Turrigiano,et al.  Activity-dependent synaptic GRIP1 accumulation drives synaptic scaling up in response to action potential blockade , 2015, Proceedings of the National Academy of Sciences.

[31]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[32]  T. Boeckers,et al.  The PSD protein ProSAP2/Shank3 displays synapto-nuclear shuttling which is deregulated in a schizophrenia-associated mutation , 2014, Experimental Neurology.

[33]  D. Stellwagen,et al.  TNF-α Downregulates Inhibitory Neurotransmission through Protein Phosphatase 1-Dependent Trafficking of GABAA Receptors , 2013, The Journal of Neuroscience.

[34]  Gina G. Turrigiano,et al.  How to Scale Down Postsynaptic Strength , 2013, The Journal of Neuroscience.

[35]  J. Buxbaum,et al.  SHANK3 haploinsufficiency: a “common” but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders , 2013, Molecular Autism.

[36]  Rodrigo Lopez,et al.  Analysis Tool Web Services from the EMBL-EBI , 2013, Nucleic Acids Res..

[37]  M. Ehlers,et al.  Modeling Autism by SHANK Gene Mutations in Mice , 2013, Neuron.

[38]  M. Sheng,et al.  GKAP/SAPAP orchestrates activity-dependent postsynaptic protein remodeling and homeostatic scaling , 2012, Nature Neuroscience.

[39]  D. Higgins,et al.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.

[40]  T. Boeckers,et al.  Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies. , 2011, Trends in cell biology.

[41]  E. Thiels,et al.  Protein phosphatases 1 and 2A are both required for long‐term depression and associated dephosphorylation of cAMP response element binding protein in hippocampal area CA1 in vivo , 2011, Hippocampus.

[42]  S. Carr,et al.  Cdk5 Is Required for Memory Function and Hippocampal Plasticity via the cAMP Signaling Pathway , 2011, PloS one.

[43]  M. Chiappalone,et al.  Importance of Shank3 Protein in Regulating Metabotropic Glutamate Receptor 5 (mGluR5) Expression and Signaling at Synapses , 2011, The Journal of Biological Chemistry.

[44]  G. Turrigiano Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement. , 2011, Annual review of neuroscience.

[45]  G. Turrigiano,et al.  PSD-95 and PSD-93 Play Critical But Distinct Roles in Synaptic Scaling Up and Down , 2011, The Journal of Neuroscience.

[46]  R. Huganir,et al.  Homeostatic Scaling Requires Group I mGluR Activation Mediated by Homer1a , 2010, Neuron.

[47]  Gary D Bader,et al.  Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation , 2010, PloS one.

[48]  Rodrigo Lopez,et al.  A new bioinformatics analysis tools framework at EMBL–EBI , 2010, Nucleic Acids Res..

[49]  Huilin Li,et al.  The Postsynaptic Density Proteins Homer and Shank Form a Polymeric Network Structure , 2009, Cell.

[50]  G. Turrigiano The Self-Tuning Neuron: Synaptic Scaling of Excitatory Synapses , 2008, Cell.

[51]  G. Turrigiano,et al.  Rapid Synaptic Scaling Induced by Changes in Postsynaptic Firing , 2008, Neuron.

[52]  Steven P Gygi,et al.  A probability-based approach for high-throughput protein phosphorylation analysis and site localization , 2006, Nature Biotechnology.

[53]  R. Malenka,et al.  Synaptic scaling mediated by glial TNF-α , 2006, Nature.

[54]  Eckart D Gundelfinger,et al.  An Architectural Framework That May Lie at the Core of the Postsynaptic Density , 2006, Science.

[55]  C. Bessant,et al.  i-Tracker: For quantitative proteomics using iTRAQ™ , 2005, BMC Genomics.

[56]  R. Huganir,et al.  Ribosomal S6 kinase 2 interacts with and phosphorylates PDZ domain-containing proteins and regulates AMPA receptor transmission. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[57]  I. Grundke‐Iqbal,et al.  Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. , 2005, The American journal of pathology.

[58]  T. Boeckers,et al.  C‐terminal synaptic targeting elements for postsynaptic density proteins ProSAP1/Shank2 and ProSAP2/Shank3 , 2005, Journal of neurochemistry.

[59]  R. Colbran,et al.  Protein Phosphatases and Calcium/Calmodulin-Dependent Protein Kinase II-Dependent Synaptic Plasticity , 2004, The Journal of Neuroscience.

[60]  S. Nelson,et al.  Homeostatic plasticity in the developing nervous system , 2004, Nature Reviews Neuroscience.

[61]  M. Ito,et al.  Protein phosphatase 2A inhibition induces cerebellar long-term depression and declustering of synaptic AMPA receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[62]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[63]  M. Ehlers Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system , 2003, Nature Neuroscience.

[64]  Roberto Malinow,et al.  PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity , 2003, Nature Neuroscience.

[65]  S. Gygi,et al.  Proteomics: the move to mixtures. , 2001, Journal of mass spectrometry : JMS.

[66]  M. Ubukata,et al.  Tautomycetin is a novel and specific inhibitor of serine/threonine protein phosphatase type 1, PP1. , 2001, Biochemical and biophysical research communications.

[67]  J. David Sweatt,et al.  Roles of serine/threonine phosphatases in hippocampel synaptic plasticity , 2001, Nature Reviews Neuroscience.

[68]  P. Worley,et al.  Shank, a Novel Family of Postsynaptic Density Proteins that Binds to the NMDA Receptor/PSD-95/GKAP Complex and Cortactin , 1999, Neuron.

[69]  Niraj S. Desai,et al.  Activity-dependent scaling of quantal amplitude in neocortical neurons , 1998, Nature.

[70]  R. Honkanen,et al.  Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A , 1997, FEBS letters.

[71]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[72]  J. Yates,et al.  An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database , 1994, Journal of the American Society for Mass Spectrometry.

[73]  P. Cohen,et al.  An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues , 1989, FEBS letters.

[74]  D. Hartshorne,et al.  Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. , 1989, Biochemical and biophysical research communications.

[75]  A. Takai,et al.  Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. , 1988, The Biochemical journal.

[76]  J. Buxbaum,et al.  SHANK 3 haploinsufficiency : a ” common ” but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders , 2018 .

[77]  R. Colbran,et al.  CaMKII: a molecular substrate for synaptic plasticity and memory. , 2014, Progress in molecular biology and translational science.

[78]  A. Dosemeci,et al.  Regulation of phosphorylation at the postsynaptic density during different activity states of Ca2+/calmodulin-dependent protein kinase II. , 2010, Biochemical and biophysical research communications.

[79]  T. Abel,et al.  Regulation of hippocampus-dependent memory by cyclic AMP-dependent protein kinase. , 2008, Progress in brain research.

[80]  R. Malenka,et al.  Synaptic scaling mediated by glial TNF-alpha. , 2006, Nature.

[81]  W. Lederer,et al.  Effects of PP1/PP2A inhibitor calyculin A on the E-C coupling cascade in murine ventricular myocytes. , 2002, American journal of physiology. Heart and circulatory physiology.